MD vs ACHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

MD

44.3
AI Score
VS
MD Wins

ACHC

37.6
AI Score

Investment Advisor Scores

MD

44score
Recommendation
HOLD

ACHC

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric MD ACHC Winner
Forward P/E 9.2937 15.8228 MD
PEG Ratio 0.2433 1.3745 MD
Revenue Growth 1.7% -0.4% MD
Earnings Growth -29.8% -63.6% MD
Tradestie Score 44.3/100 37.6/100 MD
Profit Margin 7.7% -33.4% MD
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY MD

Relative Price Performance (Last 90 Days)

MD 1M: +18.2% · 3M: +19.3% ACHC 1M: +28.3% · 3M: +28.3%

Current Technical Phase

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.9% over 20 days), RSI 67

RSI (14): 66.7 · Price: $31.45

ACHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.7% over 20 days), RSI 79

RSI (14): 79.5 · Price: $38.80

Fundamentals Snapshot

Metric MD ACHC
Market Cap — —
Forward P/E 12.7 19.0
Trailing P/E 17.3 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.4%
Operating Margin 0.1% 0.1%
EPS 1.83 -12.44
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.